Effect of sorbinil and ascorbic acid on-myo-inositol transport in cultured rat Schwann cells exposed to elevated extracellular glucose

Journal of Neurochemistry

Volumn 69, Issue 5, 1997, Pages 2011-2018

  Karihaloo, Anil K ^a,b   Joshi, Kusum ^a   Chopra, Jagjit S ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Ascorbic acid; Diabetic neuropathy; Glucose; Myo Inositol; Schwann cells; Sorbinil

Indexed keywords

ALDOSE REDUCTASE INHIBITOR; ASCORBIC ACID; GLUCOSE; INOSITOL; SORBINIL;

ANIMAL CELL; ARTICLE; CELL TRANSPORT; CONTROLLED STUDY; DIABETIC NEUROPATHY; HYPERGLYCEMIA; MYELINATION; NONHUMAN; OSMOREGULATION; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RAT; SCHWANN CELL;

ANIMALIA;

EID: 0030813066     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1997.69052011.x     Document Type: Article

References (71)

1. 3H]glycerol into glycerolipids of sciatic nerve from streptozotocin diabetic rat. J. Neurochem. 45, 465-469.
2. Brockes J. P., Fields K. L., and Raff M. C. (1979) Studies on cultured rat Schwann cells. I. Establishment of purified populations from cultures of peripheral nerve. Brain Res. 165, 105-118.
3. 3H]inositol uptake by glucose and sorbitol in cultured bovine lens epithelial cells. Restoration of myo-inositol uptake by aldose reductase inhibition. Invest. Ophthalmol. Vis. Sci. 33, 3561-3571.
4. +-ATPase defect in experimental diabetic neuropathy. Diabetes 35, 1282-1285.
5. Chalvardjian A. and Rudnicki E. (1970) Determination of lipid phosphorus in the nanomolar range. Anal. Biochem. 36, 225-226.
6. Chopra J. S. and Hurwitz L. J. (1969) A comparative study of peripheral nerve conduction in diabetic and non-diabetic chronic occlusive peripheral vascular disease. Brain 92, 83-96.
7. Chopra J. S., Hurwitz L. J., and Montgomery D. A. D. (1969) The pathogenesis of sural nerve changes in diabetes mellitus. Brain 92, 391-418.
8. Clements R. S. Jr. (1979) Diabetic neuropathy: new concepts of its etiology. Diabetes 28, 605-611.
9. Clements R. S. Jr. and Stockard C. R. (1980) Abnormal sciatic nerve myo-inositol metabolism in the streptozotocin diabetic rat. Diabetes 29, 227-235.
10. Cunningham J. J., Mearkle P. L., and Brown R. G. (1994) Vitamin C: an aldose reductase inhibitor that normalizes erythrocyte sorbitol in insulin dependent diabetes mellitus. J. Am. Coll. Nutr. 13, 344-350.
11. Del Monte M. A., Rabbani R., Diaz T. C., Lattimer S. A., Nakamura J., Brennan M. C., and Greene D. A. (1991) Sorbitol, myo-inositol and rod outer segment phagocytosis in cultured hRPE cells exposed to glucose. In vitro model of myo-inositol depletion hypothesis of diabetic complications. Diabetes 40, 1335-1345.
12. Dubois-Dalcq M., Rentier B., Evercooren B., and Bunge B. W. (1981) Structure and behaviour of rat primary and secondary Schwann cells in vitro. Exp. Cell Res. 131, 283-297.
13. Ellenberg M. (1983) Diabetic neuropathy, in Diabetes Mellitus: Principles and Practice (Ellenberg M. and Rifkin H., eds), pp. 777-802. Medical Examination Publishing Co., New York.
14. Fields K. L., Brockes J. P., Mirsky R., and Wendon L. M. B. (1978) Cell surface markers for distinguishing different types of rat dorsal root ganglion cells in culture. Cell 14, 43-51.
15. Florkowski C. M., Rome B. R., Nightingale S., Homey T. C., and Barnett A. H. (1991) Clinical and neurophysiological studies of aldose reductase inhibitor ponalrestat in chronic symptomatic diabetic peripheral neuropathy. Diabetes 40, 129-133.
16. Gabbay K. H. and O'Sullivan J. B. (1968) The sorbitol pathway enzyme localization and content in normal and diabetic nerve and cord. Diabetes 17, 239-243.
17. Gilliatt J. A. and Williamson R. G. (1962) Peripheral nerve conduction in diabetic neuropathy. J. Neurol. Neurosurg. Psychiatry 25, 11-18.
18. Gillon K. R. W. and Hawthorne J. N. (1983) Transport of myoinositol into endoneurial preparations of sciatic nerve from normal and streptozotocin diabetic rats. Biochem. J. 210, 775-781.
19. Gillon K. R. W., Hawthorne J. N., and Tomlinson D. R. (1983) myo-Inositol and sorbitol metabolism in relation to peripheral nerve function in experimental diabetes in the rat: the effect of aldose reductase inhibition. Diabetologia 25, 365-371.
20. Greene D. A. and Lattimer S. A. (1983) Impaired rat sciatic nerve sodium-potassium adenosine triphosphatase in acute streptozotocin diabetes and its correction by dietary myo-inosilol supplementation. J. Clin. Invest. 72, 1058-1063.
21. Greene D. A. and Lattimer S. A. (1984) Action of sorbinil in diabetic peripheral nerve: relationship of polyol pathway inhibition to a myo-inositol mediated defect in sodium-potassium ATPase activity. Diabetes 33, 712-716.
22. Greene D. A. and Winegrad A. I. (1981) Effects of acute experimental diabetes on composite energy metabolism in peripheral nerve axons and Schwann cells. Diabetes 30, 967-974.
23. Greene D. A., DeJesus P. V., and Winegrad A. I. (1975) Effects of insulin and dietary myo-inositol on impaired peripheral motor nerve conduction velocity in acute streptozotocin diabetes. J. Clin. Invest. 55, 1326-1336.
24. Greene D. A., Lewis R. A., Lattimer S. A., and Brown M. J. (1982) Selective effects of myo-inositol administration on sciatic and tibial motor nerve conduction parameters in the streptozotocin-diabetic rat. Diabetes 31, 573-578.
25. Greene D. A., Chakrabarti S., Lattimer S. A., and Sima A. A. F. (1987a) Role of sorbitol accumulation and myo-inositol depletion in paranodal swelling of large myelinated nerve fibers in the insulin deficient spontaneously diabetic biobreeding rat. J. Clin. Invest. 79, 1479-1485.
26. Greene D. A., Lattimer S. A., and Sima A. A. F. (1987b) Sorbitol phosphoinositides and sodium-potassium ATPase in the pathogenesis of diabetic complications. N. Engl. J. Med. 316, 599-606.
27. Greene D. A., Lattimer S. A., and Sima A. A. F. (1988) Pathogenesis and prevention of diabetic neuropathy. Diabetes Metab. Rev. 4, 201-221.
28. Greene D. A., Sima A. A., Stevens M. J., Feldman E. L., and Lattimer S.A. (1992) Complications: neuropathy, pathogenetic considerations. Diabetes Care 15, 1902-1925.
29. Greene D. A., Arezzo J., and Brown M. (1996) Dose-related effects of the aldose reductase on nerve conduction velocity and nerve fiber density in human diabetic neuropathy. Diabetes 45(Suppl. 2), 190A.
30. Hawthorne G. C., Bartlett K., Hetherington C. S., and Alberti K. G. M. M. (1989) The effect of high glucose on polyol pathway activity and myo-inositol metabolism in cultured human endothelial cells. Diabetologia 32, 163-166.
31. Hothersall J. S. and Mclean P. (1979) Effect of experimental diabetes and insulin on phosphatidylinositol synthesis in rat sciatic nerve. Biochem. Biophys. Res. Commun. 88, 477-484.
32. Judzewitsch R. G., Jaspan J. B., Polonsky K. S., Weinberg C. R., Halter J. B., Halar E., Pfeifer M. A., Vukadinovic C., Bernstein L., Schneider M., Liang K. Y., Gabbay K. H., Runenstein A. H., and Porte D. Jr. (1983) Aldose reductase inhibition improves nerve conduction velocity in diabetic patients. N. Engl. J. Med. 308, 119-125.
33. Kato N., Mizuno K., Matsubara A., Nakano K., Kurono M., and Yagihashi S. (1994) Effect of long term treatment with a new aldose reductase inhibitor (2S,4S)-6-fluoro-2′,5′-dioxospiro-[chroman-4-4′-imidazoldine]- 2-carboxyamide (SNK-860), on peripheral neuropathy in streptozotocin induced diabetic rats. J. Diabetes Complications 8, 27-32.
34. Kaur U., Chopra J. S., Prabhakar S. K., and Radhakrishnan K. (1982) Clinical spectrum of peripheral neuropathies. Indian J. Med. Res. 76, 728-735.
35. Khatami M. and Rockey J. H. (1988) Regulation of uptake of inositol by glucose in cultured retinal pigment epithelial cells. Biochem. Cell Biol. 66, 951-957.
36. Khatami M., Stramm L. E., and Rockey J. H. (1986) Ascorbate transfer in cultured cat retinal pigment epithelial cells. Exp. Eye Res. 43, 607-612.
37. Kikkawa R., Hatanaka I., Yasuda H., et al. (1984) Prevention of peripheral nerve dysfunction by an aldose reductase inhibitor in streptozotocin diabetic rats. Metabolism 33, 212-214.
38. Kusama H. and Stewart M. A. (1970) Levels of myo-inositol in normal and degenerating peripheral nerve. J. Neurochem. 17, 317-323.
39. Lees M. B. and Paxman S. C. (1972) Modification of Lowry procedure for the analysis of proteolipid protein. Anal. Biochem. 47, 184-192.
40. Li W., Khatami M., and Rockey J. H. (1985) The effects of glucose and an aldose reductase inhibitor on the sorbitol content and collagen synthesis of bovine retinal capillary pericytes in culture. Exp. Eye Res. 40, 439-444.
41. Lorenzi M., Toedo S., Boss G. R., Lane M. J., and Montisano D. F. (1987) The polyol pathway and glucose 6-phosphate in human endothelial cells cultured in high glucose concentrations. Diabetologia 30, 222-227.
42. MacGregor L. C. and Matschinsky F. M. (1986) Experimental diabetes mellitus impairs the function of the retinal pigmented epithelium. Metabolism 35(Suppl. 1), 28-34.
43. Malone J. I., Leavengood H., Peterson M. J., O'Brien M. M., Page M. G., and Aldinger C. E. (1984) Red blood cell sorbitol as an indicator of polyol pathway activity: inhibition by sorbinil in insulin-dependent diabetic subjects. Diabetes 33, 45-49.
44. Manthorpe M., Skaper S. D., and Varon S. (1980) Purification of mouse Schwann cells using neurite-induced proliferation in serum free monolayer culture. Brain Res. 196, 467-482.
45. Mayer J. H. and Tomlinson D. R. (1983) Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or an aldose reductase inhibitor in streptozotocin-diabetic rat. Diabetologia 25, 433-438.
46. Mayhew J. A., Gillon K. R. W., and Hawthorne J. N. (1983) Free and lipid inositol, sorbitol and sugars obtained postmortem from diabetic and control subjects. Diahetologia 24, 13-15.
47. Moore B. W. (1972) Chemistry and biology of two proteins. S-100 and 14-3-2, specific to the nervous system. Int. Rev. Neurobiol. 15, 215-225.
48. Moore B. W. and Perez V. J. (1968) Specific acidic proteins of the nervous system, in Physiological and Biochemical Aspects of Nervous Integration (Carlson F. D., ed), pp. 343-360. Prentice Hall, Englewood Cliffs, New Jersey.
49. Mulder D. W., Lambert E. H., Bastron J. A., and Sprague R. G. (1961) The neuropathies associated with diabetes mellitus: a clinical and electromyographic study of 103 unselected diabetic patients. Neurology 11, 275-284.
50. Murray M. R. and Stout A. P. (1942) Characteristics of human Schwann cells in vitro. Anat. Rec. 84, 275-294.
51. Organisciak D. T., Wang H. M., Li Z. Y., and Tso M. O. (1985) The protective effect of ascorbate in retinal light damage of rats. Invest. Ophthalmol. Vis. Sci. 26, 1580-1588.
52. Palmano K. P., Whiting P. H., and Hawthorne J. N. (1977) Free and lipid myo-inositol in tissues from rats with acute and less severe streptozotocin induced diabetes. Biochem. J. 167, 229-235.
53. Pederson M. M., Christiansen J. S., and Mogensen C. E. (1991) Reduction of glomerular hyperfiltration in normoalbuminuric IDDM patients by 6 months of aldose reductase inhibitor. Diabetes 49, 527-531.
54. Pfeiffer S. E. (1973) Clonal lines of glial cells, in Tissue Culture of Nervous System (Sato G., ed), pp. 203-210. Plenum Press, New York.
55. Segal S., Hwang S. M., Stern J., and Pleasure D. (1984) Inositol uptake by cultured rat Schwann cells. Biochem. Biophys. Res. Commun. 120, 486-492.
56. Shindo H., Thomas T. P., Larkin D. D., Karihaloo A. K., Inada H., Onaya T., Stevens M. J., and Greene D. A. (1996) Modulation of basal nitric oxide dependent cyclic GMP production by ambient glucose, myo-inositol and protein kinase C in SH-SY5Y human neuroblastoma cells. J. Clin. Invest. 97, 736-745.
57. Spielberg S. P., Shear N. H., Cannon M., Hutson N. J., and Gunderson K. (1991) In vitro assessment of a hypersensitivity syndrome associated with sorbinil. Ann. Intern. Med. 114, 720-724.
58. Thomas T. P., Porcelati F., Kalo K., Stevens M. J., Sherman W. R., and Greene D. A. (1994) Effects of glucose on sorbitol pathway activation, cellular redox and metabolism of myo-inositol, phosphoinositides and diacylglycerol in cultured human retinal pigmented epithelial cells. J. Clin. Invest. 93, 2718-2724.
59. Traynor-Kaplan A. E., Harris A. L., Thompson B. L., Taylor P., and Sklar L. A. (1988) An inositol tetrakisphosphate containing phospholipid in activated neutrophils. Nature 334, 353-356.
60. Varma S. D., Kumar S., and Richards R. D. (1979) Light-induced damage to ocular lens cation pump prevention by vitamin C. Proc. Natl. Acad. Sci. USA 76, 3504-3506.
61. Varon S. and Raiborn C. W. (1971) Excitability and conduction in neurons of dissociated ganglionic cell cultures. Brain Res. 30, 83-98.
62. Varon S. and Somjen G. G. (1979) Neuron-glia interactions. Neurosci. Res. Program Bull. 17, 1-239.
63. Vinson J. A., Staretz M. E., Bose P., Kassm H. M., and Basalyga B. S. (1989 ) In vitro and in vivo reduction of erythrocyte sorbitol by ascorbic acid. Diabetes 38, 1036-1041.
64. Wang H., Zhang Z., Wen R., and Chen J. (1995) Experimental and clinical studies on the reduction of erythrocyte sorbitol-glucose ratios by ascorbic acid in diabetes mellitus. Diabetes Res. Clin. Pract. 28, 1-8.
65. Whiting P. H., Palmano K. P., and Hawthorne J. N. (1979) Enzymes of myo-inositol and inositol lipid metabolism in rats with streptozotocin induced diabetes. Biochem. J. 179, 549-553.
66. Williamson J. R., Chang K., Rowold E., Marvel J., Tomlinson M., Sherman W. R., Ackermann K. E., and Kilo C. (1985) Sorbinil prevents diabetes induced increases in vascular permeability but does not alter collagen cross linking. Diabetes 34, 703-705.
67. Williamson J. R., Chang K., Frangos M., Hanson K. S., Ido Y., Kawamura T., Nyengaard J. R., van den Enden M., Kilo C., and Tilton R. G. (1993) Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 42, 801-813.
68. Winegrad A. I. (1987) Does a common mechanism induce the diverse complications of diabetes? Diabetes 36, 396-406
69. Yorek M. A., Dunlap J. A., and Ginsberg P. H. (1987) myo-Inositol metabolism in 41A3 neuroblastoma cells: effects of high glucose and sorbitol levels. J. Neurochem. 48, 53-61.
70. Yorek M. A., Dunlap J. A., and Ginsberg B. H. (1988) Effect of sorbinil on myo-inositol metabolism in cultured neuroblastoma cells exposed to increased glucose levels. J. Neurochem. 51, 331-338.
71. Young R. J., Ewing D. J., and Clarke B. F. (1983) A controlled trial of sorbinil and aldose reductase inhibitor in chronic painful diabetic neuropathy. Diabetes 32, 938-942.